The EarliPoint® System
What is EarliPoint Evaluation?
EarliPoint is an FDA-cleared eye-tracking assessment tool designed for young children (16–30 months) to aid in the diagnosis and evaluation of autism spectrum disorder (ASD).
How it works:
During the assessment, your child watches a series of short, engaging videos of social interactions while the device tracks their eye movements. EarliPoint measures how your child looks at faces, gestures, and social cues, collecting over 100 data points per second. This information is compared to age-based norms to provide objective insights into your child’s social attention and communication development.
Who interprets the results:
EarliPoint enables earlier and more accurate identification of developmental differences. A pediatrician reviews the results with you and provides a diagnosis and resources when applicable. Should you choose to work with us, a BCBA from our agency may also interpret the results and use them as a guide when creating an ABA program. In addition, the assessment may be readministered to current clients in 6 months to assess progress.​​​​
What to expect:
Your child will sit comfortably and watch videos on a screen while the device collects data. EarliPoint data does not replace a clinical evaluation, but it provides valuable, objective insight to help us better support your child’s growth and learning. Our team will be available during and after the evaluation to address any questions.​​​​​​​
​
*The EarliPoint System (EarliTec Diagnostics, Inc.) device is indicated as a tool to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children as early as 16 months, who are at risk based on concerns identified by a parent, caregiver, or healthcare provider. Not for direct consumer purchase; clinician use only.